Buscar
01/08/2025
From cadaveric donation to cryopreserved total skin allografts: Transforming the Chilean skin donation model
Fonseca, M, Cañete, A, Mandriaza, L, Gómez, J, Masiá, J, Marcelain, K, Ibaceta, D, Erazo, C, Gamez, B, Soto, C, Valdés, C. From cadaveric donation to cryopreserved total skin allografts: Transforming the Chilean skin donation model. BURNS. 2025; 51(6)DOI:10.1016/j.burns.2025.107563. PMID:40480064. IF:2.900(Q1/2D).
01/08/2025
European Association of Urology-European Society of Paediatric Urology Guidelines on Paediatric Urology: Summary of 2024 Updates. Part II
Skotta, M, Kennedy, U, Gnech, M, van Uitert, A, Bujons, A, Hoenf, L', Rawashdeh, YF, Silayg, MS, O'Kellyh, F, Quaedackers, J, Pakkasjarvij, N, Yuan, YH, Burgu, B, Castagnetti, M, Bogaertp, G, Radmayrq, C. European Association of Urology-European Society of Paediatric Urology Guidelines on Paediatric Urology: Summary of 2024 Updates. Part II. EUROPEAN UROLOGY. 2025; 88(2)DOI:10.1016/j.eururo.2025.02.022. PMID:40118740. IF:25.200(Q1/1D).
01/08/2025
Early diuretic response and outcome prediction in ambulatory worsening heart failure: Natriuresis versus diuresis
Marcos, MC, de la Espriella, R, Zegri-Reiriz, I, Llacer, P, Gracia, JR, Comín-Colet, J, Morales-Rull, JL, Diez-Villanueva, P, Baguda, JD, Jimenez-Marrero, S, Cortés, CO, Restrepo-Córdoba, MA, García-Pinilla, JM, Barrios, E, Díaz, SD, Núñez, J. Early diuretic response and outcome prediction in ambulatory worsening heart failure: Natriuresis versus diuresis. ESC Heart Failure. 2025; 12(4)DOI:10.1002/ehf2.15275. PMID:40152188. IF:3.700(Q1/3D).
01/08/2025
Initial Experience of Orthotopic Tricuspid Valve Replacement in Spain: TRI-SPA Replace Registry
Echarte-Morales, J, Barreiro-Pérez, M, Nombela-Franco, L, Freixa, X, Cruz-González, I, Sánchez-Recalde, A, Arzamendi, D, Baz, JA, Mon, M, Sanchis, L, Laffond, AE, Rodríguez, LMD, Li, CH, Jiménez, P, Altisent, OAJ, Blanco, F, Fernández-Golfin, C, Menduiña, I, Estévez-Loureiro, R. Initial Experience of Orthotopic Tricuspid Valve Replacement in Spain: TRI-SPA Replace Registry. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. 2025; 106(2)DOI:10.1002/ccd.31662. PMID:40464478. IF:2.100(Q3/6D).
01/08/2025
Impact of intensive versus nonintensive antithrombotic treatment on device-related thrombus after left atrial appendage closure
Garot, P, Cepas-Guillén, P, Flores-Umanzor, E, Leduc, N, Bajoras, V, Perrin, N, McInerney, A, Lafond, A, Farjat-Pasos, J, Millan, X, Zendjebil, S, Ibrahim, R, Salinas, P, de Backer, O, Cruz-González, I, Arzamendi, D, Sanchis, L, Nombela-Franco, L, OHara, G, Aminian, A, Nielsen-Kudsk, JE, Rodés-Cabau, J, Freixa, X. Impact of intensive versus nonintensive antithrombotic treatment on device-related thrombus after left atrial appendage closure. REVISTA ESPANOLA DE CARDIOLOGIA. 2025; 78(8)DOI:10.1016/j.rec.2024.11.006. PMID:39645198. IF:4.900(Q1/2D).
01/08/2025
Key priorities for the implementation of the 2023 ESC Guidelines for the management of endocarditis in low-resource settings
Borger, MA, de Waha, S, Marsan, NA, Zühlke, L, Mestres, CA, Fosbol, E, Bonaros, N, Pizzi, MN, Brida, M, Sionis, A, Delgado, V, Task Force ESC Guidelines Management endocarditis. Key priorities for the implementation of the 2023 ESC Guidelines for the management of endocarditis in low-resource settings. European Heart Journal-Quality of Care and Clinical Outcomes. 2025; 11(5)DOI:10.1093/ehjqcco/qcae106. PMID:40152919. IF:4.600(Q1/2D).
01/08/2025
Effects of routine invasive management on reinfarction risk in older adults with frailty and non-ST-segment elevation myocardial infarction: a subanalysis of a randomised clinical trial
Sanchis, J, Bueno, H, Sánchez, DM, Martinez-Selles, M, Villanueva, PD, Barrabes, JA, Marin, F, Villa, A, Fernandez, MS, Llibre, C, Sionis, A, Elizaga, J, Alfonso, F, Nuñez, E, Núñez, J, Kunadian, V, Ariza-Solé, A. Effects of routine invasive management on reinfarction risk in older adults with frailty and non-ST-segment elevation myocardial infarction: a subanalysis of a randomised clinical trial. HEART. 2025; 111(16)DOI:10.1136/heartjnl-2024-325254. PMID:39922692. IF:4.400(Q1/3D).
01/08/2025
Changes in LDL-cholesterol assessment, goal attainment and treatments in patients with acute coronary syndromes over the years 2018, 2022 and 2024: The ACS Europath survey
Laufs, U, De Caterina, R, Schiele, F, Sionis, A, Zaman, A, Catapano, A. Changes in LDL-cholesterol assessment, goal attainment and treatments in patients with acute coronary syndromes over the years 2018, 2022 and 2024: The ACS Europath survey. ATHEROSCLEROSIS. 2025; 407DOI:. PMID:. IF:5.700(Q1/1D).